Belgium· BE-AMP-SAM511484-00
Mama Natura Gastro
A medicinal product containing croton tiglium, registered in Belgium by Schwabe Pharma Belgium.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Croton tiglium
- Manufacturer
- Schwabe Pharma Belgium
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3137114
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Croton tiglium in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/38464d74-0463-4139-b855-3d040bc87940 GET /v1/drugs/38464d74-0463-4139-b855-3d040bc87940?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Mama Natura Gastro",
"name_fr": "Mama Natura Gastro",
"name_nl": "Mama Natura Gastro",
"amp_code": "SAM511484-00",
"strengths": [
"20.0000",
"20.0000",
"20.0000",
"20.0000"
],
"pack_count": 1,
"substances": [
"Croton tiglium",
"Veratrum album",
"Okoubaka aubrevillei",
"Lactose Monohydrate"
],
"medicine_type": "HOMEOPATHIC",
"atc_description": null,
"authorisation_numbers": [
"HO-BE511484"
]
}See everything about croton tiglium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.